Nanoparticle formulation by Büchi b-90 nano spray dryer for oral mucoadhesion

Drug Design, Development and Therapy

Volumn 9, Issue , 2015, Pages 273-282

  Harsha, Sree N ^a   Aldhubiab, Bander E ^a   Nair, Anroop B ^a   Alhaider, Ibrahim Abdulrahman ^a   Attimarad, Mahesh ^a   Venugopala, Katharigatta N ^a   Srinivasan, Saminathan ^b   Gangadhar, Nagesh ^b   Asif, Afzal Haq ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b East Point College of Pharmacy   (India)

Author keywords

Buchi Nano Spray Dryer; Diabetes; Nanospheres; Vildagliptin

Indexed keywords

GELATIN; NANOPARTICLE; NANOSPHERE; VILDAGLIPTIN; ADAMANTANE; ANTIDIABETIC AGENT; NITRILE; PYRROLIDINE DERIVATIVE;

ANGLE OF REPOSE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSPORT; GASTROINTESTINAL MUCOSA; GENERAL DEVICE; MALE; MUCOADHESION; NONHUMAN; PARTICLE SIZE; RAT; SHELF LIFE; SPRAY DRYER; SPRAY DRYING; STORAGE TEMPERATURE; ADHESION; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; SURFACE PROPERTY;

ADAMANTANE; ADHESIVENESS; ADMINISTRATION, ORAL; DRUG DELIVERY SYSTEMS; GELATIN; HUMANS; HYPOGLYCEMIC AGENTS; NANOPARTICLES; NITRILES; PARTICLE SIZE; PYRROLIDINES; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 84921976634     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S66654     Document Type: Article

References (57)

1. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Survey of Ophthalmology. 2012;57(4):347-370.
2. Dong HQ, Li M, Zhu F, Liu FL, Huang JB. Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against a-glucosidase and a-amylase linked to type 2 diabetes. Food Chem. 2011;130(2): 261-266.
3. Kikuchi M, Haneda M, Koya D, et al. Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2010;89(3):216-223.
4. Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health. 2005;4(1):2.
5. Farag YM, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26(1):28-35.
6. Kheir N, Zaidan M, Younes H, Hajj ME, Wilbur K, Jewesson PJ. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2009;72(6):133.
7. Elhadd TA, Al-Amoudi AA, Alzahrani AS. Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: a review. Am J Pharm Educ. 2007;27(4):241-250.
8. [No authors listed]. Summary of the –Stakeholder opinions: type 2 diabetes in the UAE and Saudi Arabia growth opportunities in fragmented markets— report. Datamonitor. 2008;12:241-250.
9. Kikuchi M, Abe N, Kato M, Terao S, Mimori N, Tachibana H. Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2009; 83(2):233-240.
10. Ahren B, Schweizer A, Dejager S, Villhauer EB, Dunning BE, Foley JE. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. Diabetes Obes Metab. 2011;13(9):775-783.
11. Nauck M, Schmidt W, Meier J. The incretin modulators incretin mimetics (GLP-1 receptor agonists) and incretin enhancers (DPP-4 inhibitors). In: Mogensen C, editor. Pharmacotherapy of Diabetes: New Developments. New York: Springer; 2007:111-141.
12. Morimoto K, Chono S, Kosai T, Seki T, Tabata Y. Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs. DrugDeliv. 2008;15(2):113-117.
13. Tabata Y, Ikada Y. Protein release from gelatin matrices. Adv Drug Deliv Rev. 1998;31(3):287-301.
14. Hao Z, Wu H, Hao L, et al. Preparation, characterization, and release behavior of ceftiofur-loaded gelatin-based microspheres. J Appl Polym Sci. 2013;130(4):2369-2376.
15. Cremers HF, Feijen J, Kwon G, et al. Albumin-heparin microspheres as carriers for cytostatic agents. J Control Release. 1990; 11(1 3): 167-179.
16. Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release. 1985;2: 257-275.
17. Wang J, Tabata Y, Bi D, Morimoto K. Evaluation of gastric mucoad-hesive properties of aminated gelatin microspheres. J Control Release. 2001;73(2 3):223-231.
18. Wang J, Tauchi Y, Deguchi Y, Morimoto K, Tabata Y, Ikada Y. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Drug Deliv. 2000;7(4): 237-243.
19. He YL, Serra D, Wang Y, et al. Pharmacokinetics and pharmacody-namics of vildagliptin in patients with type 2 diabetes mellitus. Clin Pharmacokinet. 2007;46(7):577-588.
20. Keating GM. Vildagliptin: a review of its use in type 2 diabetes mellitus. Drugs. 2010;70(16):2089-2112.
21. Singh B, Chakkal SK, Ahuja N. Formulation and Optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech. 2006;7(1):E3.
22. Ponchel G, Irache J-M. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev. 1998;34 2 3:191-219.
23. Bernkop-Schnürch A. Mucoadhesive systems in oral drug delivery. DrugDiscov Today Technol. 2005;2(1):83-87.
24. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1-R4.
25. Bilati U, Allémann E, Doelker E. Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol. 2003;8(1):1-9.
26. Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci. 2011;36(7): 887-913.
27. Mahajan HS, Tatiya BV, Nerkar PP. Ondansetron loaded pectin based microspheres for nasal administration: in vitro and in vivo studies. Powder Technol. 2012;221:168-176.
28. Büchi. Nano Spray Dryer B-90: the –cost saver— for small samples and particles. Available from: http://www.buchi.com/sites/default/files/downloads/B-90_Product_Brochure_en_A.pdf. Accessed March 21, 2014.
29. Su YL, Fu ZY, Zhang JY, et al. Microencapsulation of Radix salvia miltiorrhiza nanoparticles by spray-drying. Powder Technol. 2008;184(1):114-121.
30. Gupta S, Samanta M, Raichur A. Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy. AAPSPharmSciTech. 2010;11(1):322-335.
31. Harsha S. Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres. Int JNanomedicine. 2012;7:4787-4796.
32. Harsha S, Chandramouli R, Rani S. Ofloxacin targeting to lungs by way of microspheres. Int J Pharm. 2009;380(1-2):127-132.
33. Yeo JH, Lee KG, Lee YW, Kim SY. Simple preparation and characteristics of silk fibroin microsphere. Eur Polym J. 2003;39(6): 1195-1199.
34. Alexakis T, Boadi D, Quong D, et al. Microencapsulation of DNA within alginate microspheres and crosslinked chitosan membranes for in vivo application. Appl Biochem Biotechnol. 1995;50(1): 93-106.
35. Harsha NS, Aldhubiab B, Abdulrahman A, Attimarad M, Nair A. Carbopol 934-P loaded with vildagliptin for diabetic delivery: in vitro and in vivo evaluation of nanoparticles. Curr Nanosci. 2013;9(5): 642-647.
36. He YL, Sabo R, Riviere GJ, et al. Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Curr Med Res Opin. 2007;23(5):1131-1138.
37. Lu B, Zhang JQ, Yang H. Lung-targeting microspheres of carboplatin. Int J Pharm. 2003;265(1-2):1-11.
38. Radha GV, Rani TS, Sarvani B. A review on proniosomal drug delivery system for targeted drug action. J Basic Clin Pharm. 2013;4(2): 42-48.
39. Bayomi MA, al-Suwayeh SA, el-Helw AM, Mesnad AF. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. Pharm Acta Helv. 1998;73(4): 187-192.
40. Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits. AAPSPharmSciTech. 2013;14(2):782-793.
41. Dhaliwal S, Jain S, Singh HP, Tiwary AK. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation. AAPS J. 2004;10(2):322-330.
42. Mankala SK, Korla AC, Gade S. Development and evaluation of aceclofenac-loaded mucoadhesive microcapsules. J Adv Pharm Technol Res. 2011;2(4):245-254.
43. Harsha NS, Rani RH. Drug targeting to lungs by way of microspheres. Arch Pharm Res. 2006;29(7):598-604.
44. Harsha S, Attimarad M, Khan T, et al. Design and formulation of mucoadhesive microspheres of sitagliptin. J Microencapsul. 2013;30(3):257-264.
45. Cordin A, Nina S. Spray dried biodegradable polymers as target material for controlled drug delivery. Best@buchi. 2007;46.
46. Atuah KN, Walter E, Merkle HP, Alpar HO. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods. J Microencapsul. 2003;20(3):387-399.
47. Burrki K, Jeon I, Arpagaus C, Betz G. New insights into respirable protein powder preparation using a nano spray dryer. Int J Pharm. 2011; 408(1 2):248-256.
48. Schafroth N, Arpagaus C, Jadhav UY, Makne S, Douroumis D. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process. Colloids Surf B Biointerfaces. 2012,90:8-15.
49. Paulal HC, Sombral FM, Abreu FO, de Paul RC. Lippia sidoides essential oil encapsulation by angico gum/chitosan nanoparticles. J Braz Chem Soc. 2010;21(12):2359-2366.
50. Samy W, Elgindy N, El-Gowelli HM. Biopolymeric nifedipine powder for acceleration of wound healing. Int J Pharm. 2012;422(1 2): 323-331.
51. Coowanitwong I, Arya V, Kulvanich P, Hochhaus G. Slow release formulations of inhaled rifampin. AAPS J. 2008;10(2):342-348.
52. Patil P, Joshi P, Paradkar A. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS PharmSciTech. 2004;5(3):43-50.
53. Adikwu MU. Biopolymers in Drug Delivery: Recent Advances and Challenges. Sharjah: Bentham Science; 2009.
54. Pavanetto F, Genta I, Giunchedi P, Conti B. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. J Microencapsul. 1993;10(4):487-497.
55. Fu YJ, Mi FL, Wong TB, Shyu SS. Characteristic and controlled release of anticancer drug loaded poly(D,L-lactide) microparticles prepared by spray drying technique. JMicroencapsul. 2001;18(6):733-747.
56. Jadhav NR, Tone JS, Irny PV, Nadaf SJ. Development and characterization of gelatin based nanoparticles for targeted delivery of zidovudine. Int J Pharm Investig. 2013;3(3):126-130.
57. Van Der Walle C. Peptide and Protein Delivery. Amsterdam: Elsevier Science; 2011.